Market Tracker

10/30 7:05pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

35.25
Data as of Oct 30
 -0.02 / -0.06%
Today’s Change
30.80
Today|||52-Week Range
55.99
-11.63%
Year-to-Date

Today’s Trading

Previous close35.27
Today’s open35.16
Day’s range34.52 - 35.90
Volume1,399,470
Average volume (3 months)1,016,782
Market cap$4.4B
Dividend yield--
Data as of 3:59pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)-10.87%
Earnings growth (this year)-56.94%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+27.73%
P/E ratioNM
Price/Sales18.01
Price/Book18.79

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.31-0.88%
AKRXAkorn Inc+0.50+1.16%
OPKOPKO Health Inc0.000.00%
ICPTIntercept Pharmaceut...+6.40+2.56%
Data as of 4:03pm ET, 10/30/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$269.3M
Annual profit (last year)-$62.5M
Net profit margin-23.22%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer &
Secretary
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts